Search research articles
Contact Us
Filters
Showing results (491-500 of 636) with videos related to
Page
of 64
Sort By:
Journal of Cardiovascular Computed Tomography
|
July 25, 2022
Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study
Francois Haddad, Nicholas Cauwenberghs, Melissa A Daubert, et al.
American Heart Journal
|
February 11, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF
Vanessa Blumer, Manuel Rivera, Ramón Corbalán, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes
Jason J Rose, L Kristin Newby, Samuel Broderick, et al.
The New England Journal of Medicine
|
August 12, 2011
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, et al.
Journal of the American College of Cardiology
|
November 5, 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
Philippe Généreux, Gregg W Stone, Robert A Harrington, et al.
Circulation
|
September 11, 2013
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"
Jonathan P Piccini, Susanna R Stevens, Yuchiao Chang, et al.
Circulation
|
December 31, 2014
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Karen A Hicks, James E Tcheng, Biykem Bozkurt, et al.
Clinical Cardiology
|
June 30, 2019
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX
Celina M Yong, Vandana Sundaram, Freddy Abnousi, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
American Heart Journal
|
April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome
Connie N Hess, Robert M Clare, Megan L Neely, et al.
Page
of 64
Search research articles
Search
Showing results (491-500 of 636) with videos related to
Sort By:
Page
of 64
Journal of Cardiovascular Computed Tomography
|
July 25, 2022
Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study
Francois Haddad, Nicholas Cauwenberghs, Melissa A Daubert, et al.
American Heart Journal
|
February 11, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF
Vanessa Blumer, Manuel Rivera, Ramón Corbalán, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes
Jason J Rose, L Kristin Newby, Samuel Broderick, et al.
The New England Journal of Medicine
|
August 12, 2011
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, et al.
Journal of the American College of Cardiology
|
November 5, 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
Philippe Généreux, Gregg W Stone, Robert A Harrington, et al.
Circulation
|
September 11, 2013
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"
Jonathan P Piccini, Susanna R Stevens, Yuchiao Chang, et al.
Circulation
|
December 31, 2014
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Karen A Hicks, James E Tcheng, Biykem Bozkurt, et al.
Clinical Cardiology
|
June 30, 2019
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX
Celina M Yong, Vandana Sundaram, Freddy Abnousi, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
American Heart Journal
|
April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome
Connie N Hess, Robert M Clare, Megan L Neely, et al.
Page
of 64